AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + real-time funding intelligence

✓Never see duplicates in your feed

INDUSTRY FIRST

Proto Kinetix, Inc. announced it raised $100,000 in an initial filing from an offering of $100,000

Jul 10, 2015•about 10 years ago

Amount Raised

$100,000

DaltonBiotechnology

Company Information

Company

ProtoKinetix

Location

109 W. MAIN ST.

Dalton, Ohio, United States

About

ProtoKinetix (PKTX) is a research and development company leading the way in cell survival solutions. Its patented anti-aging glycopeptide (AAGP) is a revolutionary discovery with incredible opportunity to shape the future of ophthalmology, dermatology, transplant support and biomanufacturing. Based on a molecule found in nature and harnessed by a world-class research team, this anti-aging glycopeptide helps more cells survive longer and has the capability to change health care forever.

FundzWatch™ Score

100

High Activity

55 total signals

Buyer Intent Analysis

Get personalized insights on buying likelihood

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech